CNI REVIEW Medical Journal
CNI Home
 CNI Home Contents 

Spinal Cord Injury

Spring 1998
Volume 9, Number 1

  This Issue Contents

 Next Article  

Progressive Posttraumatic Myelopathies

Scott P Falci, MD

Progressive neurologic deterioration following spinal cord injury unrelated to anatomical compression of the spinal cord or spinal instability has become more widely recognized. Cystic myelopathy or posttraumatic syringomyelia as a cause of progressive neurologic deterioration has been well described. One sees a spinal cord cyst develop at the injury site, which may progressively ascend and/or descend with time. Clinically, progressive loss of sensation and strength, as well as worsening spasticity, pain, hyperhidrosis, autonomic dysreflexia, and a Horner’s Syndrome, may occur.

Introduction. Progressive neurologic deterioration following spinal cord injury unrelated to anatomical compression of the spinal cord or spinal instability has become more widely recognized. Cystic myelopathy or posttraumatic syringomyelia as a cause of progressive neurologic deterioration has been well described.1,2 One sees a spinal cord cyst develop at the injury site, which may progressively ascend and/or descend with time (Figure 1). Clinically, progressive loss of sensation and strength, as well as worsening spasticity, pain, hyperhidrosis, autonomic dysreflexia, and a Horner’s Syndrome, may occur. More recently, the noncystic posttraumatic tethered cord has been associated with identical progressive neurologic deterioration.1-3, 6 With this entity, scar tissue which forms around the spinal cord at the time of injury, fixes or tethers the cord to the dura, thereby inhibiting the normal motion of the spinal cord within the dura sac, as well as normal spinal fluid flow. (Figure 2)

Figure 1
Fig 1. This cervical MRI of a patient with spinal cord injury shows a cyst ascending from the injury site at C3-4 and a second cyst descending to the C5-6 level.
Figure 2
Fig 2. This cervical MRI of a patient with spinal cord injury shows the spinal cord tethered to the posterior spinal canal at the C6-7 level. There is no cyst.
Figure 3
Fig 3. This cervical MRI shows the spinal cord in Figure 2 after it was surgically untethered. Note the reconstituted posterior subarachnoid space.
Figure 4
Fig 4. This cervical MRI shows the spinal cord in Figure 1 after it was surgically untethered and after the cysts were shunted. Note the reconstituted posterior subarachnoid space and collapse of the cysts.

It has been suggested that posttraumatic tethering from arachnoidal scar is a necessary precursor to cyst formation, and that both cystic and noncystic entities share similar pathophysiologic mechanisms with cyst formation being an end point of a process.

Surgical treatment for both cystic and noncystic entities involves releasing the scar tissue around the spinal cord. That is, untethering the spinal cord, restoring more normal spinal fluid flow past the injury site, and adding a graft of dura to expand the subarachnoid space and minimize the chance of rescarring. If a cyst exists, a shunt tube must be placed into the cyst cavity to allow the release of cyst fluid. (Figures 3 & 4)

Surgical treatment is primarily reserved for significant and progressive loss of neurologic function. In certain cases, surgery is performed to relieve pain, spasticity, autonomic dysreflexia and hyperhidrosis, but only if these symptoms are poorly controlled with medications. Because of the medical complexity of the spinal cord injured population, surgery should be performed with the support of physiatrists, nurses, and therapists experienced with the spinal cord injured population. In experienced hands, one can expect corrective surgery for posttraumatic spinal cord cysts and tethered cords to halt the progressive loss of function, and allow for some return of lost function.1-3

Research is being performed with The Craig Center for Spinal Injury and The Karolinska Institute to find ways to permanently obliterate posttraumatic cyst cavities with biologic tissue, eliminating the need for shunt tubes. The first obliteration of a posttraumatic spinal cord cyst using a vascularized graft of omentum was performed in 1994.4 The first obliteration of a posttraumatic spinal cord cyst using human embryonic nerve cells was performed in January, 1997.5

In the later case, human embryonic nerve cells successfully grew to fill and obliterate a posttraumatic cyst cavity in a patient and halted its progress. Additional patients have since been operated on and are presently being followed in this pilot study.

Conclusion. In summary, posttraumatic cystic and tethered spinal cords can result in clinically significant neurologic deterioration months to years after a spinal cord injury. Treatment requires a surgical release of scar tissue around the spinal cord (untethering) to restore more normal motion to the cord as well as restore more normal CSF flow dynamic. Cyst cavities may require definitive shunting. The goal is primarily to halt progressive neurologic loss, but some return of lost function is often achieved. Research is underway using embryonic cellular therapy which may provide an improved treatment strategy in the future.

References

1. Edgar R, Quail P. Progressive posttraumatic cystic and non-cystic myelopathy. Brit J Neurosurg. 1994;8:7-22.
2. Falci S, Best L, Froelich J, Lammertse D. Surgical, imaging and evoked potential correlates of spinal cord and rootlet tethering in progressive post-traumatic myelopathies. J Spinal Cord Med. 1995;18:154. Abstract.
3. Lee T, Arias J, Andrus H, Quencer R, Falcone S, Green B. Progressive posttraumatic myelomalacic myelopathy; treatment with untethering and expansive duraplasty. J Neurosurg. 1997;86:624-628.
4. Falci S, Zwiebel P. Treatment of refractory progressive post-traumatic cystic myelopathy with a new technique: Myelocyst-omental grafting J of Spinal Cord Med. 1995;18:154. Abstract.
5. Falci S, Holtz A, Akesson F, et al. Obliteration of a post-traumatic spinal cord cyst with human embryonic spinal cord grafts: First clinical attempt. J of Neurotrauma. Submitted for publication.
6. Froelich J, Falci S, Lammertse D, Best L. Assessment of cord tethering by phase contrast MR CSF/flow analysis. J Spinal Cord Med. 1995;18:127.

Scott P Falci, MDScott P Falci, MD, a CNI member, is Chief Neurosurgical Consultant at Craig Hospital in Englewood, Colorado, and is Chief Neurosurgical Consultant, Spinalis SCI Research Unit, Karolinska Institute, in Stockholm, Sweden.

Back to top
Address comments and questions to:
Scott P Falci, MD
3425 South Clarkson Street
Englewood, CO 80113

  This Issue Contents

 Next Article  

 
 
Go to Swedish Medical Center website
CNI REVIEW Library  ·  CNI Publications 
Colorado Neurological Institute (CNI), 701 East Hampden Ave., Suite 330, Englewood, CO 80113
Phone: (303) 788-4010, Fax: (303) 788-5469, NPyle@TheCNI.org
The medical information presented on this website is meant for general educational purposes only.
Persons should consult their physician regarding specific medical concerns or treatment. Copyright 2007, Colorado Neurological Institute.
Privacy Policy


E-mail  to
website editor